Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Account Payables (2016 - 2025)

STRATA Skin Sciences' Change in Account Payables history spans 10 years, with the latest figure at $9000.0 for Q3 2025.

  • For Q3 2025, Change in Account Payables rose 100.77% year-over-year to $9000.0; the TTM value through Sep 2025 reached $1.2 million, up 178.78%, while the annual FY2024 figure was -$954000.0, 854.0% down from the prior year.
  • Change in Account Payables for Q3 2025 was $9000.0 at STRATA Skin Sciences, down from $103000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.1 million in Q1 2022 and bottomed at -$1.2 million in Q3 2024.
  • The 5-year median for Change in Account Payables is $128000.0 (2022), against an average of $4263.2.
  • The largest annual shift saw Change in Account Payables crashed 583.59% in 2023 before it skyrocketed 307.14% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $342000.0 in 2021, then crashed by 376.02% to -$944000.0 in 2022, then skyrocketed by 117.8% to $168000.0 in 2023, then soared by 307.14% to $684000.0 in 2024, then plummeted by 98.68% to $9000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Change in Account Payables are $9000.0 (Q3 2025), $103000.0 (Q2 2025), and $362000.0 (Q1 2025).